By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.
By continuing to browse the site you are agreeing to our use of cookies.
Find out more here.
Cyprotex have expertise in in vitro metabolism, in vitro permeability, transporters, solubility and physicochemical properties, in vitro protein binding and PK and bioanalysis.
Read more
Cyprotex use a range of HCS, MEA and biochemical endpoints to identify potential for genotoxicity, hepatotoxicity, cardiotoxicity, neurotoxicity and nephrotoxicity.
Read more
Cyprotex specializes in 2D and 3D phenotypic cell-based models using a range of different techniques such as HCS, microelectrode array, cellular bioenergetics and RT-PCR.
Read more
Cyprotex are highly experienced in QSAR and PBPK techniques, and we have developed our own proprietary software tools for accurately predicting pharmacokinetics.
Read more
Cyprotex is now part of Evotec, enabling us to offer integrated and standalone drug discovery services.
Read more
Cyprotex offer a comprehensive panel of ADME, toxicity and bioscience services for testing potential new pharmaceuticals.
Read more
Cyprotex provide in vitro genotoxicity and phototoxicity screening methods for testing personal care and cosmetic formulations.
Read more
Cyprotex supply a range of services to assess the potential toxicity of chemicals including genotoxicity and phototoxicity screening methods..
Read moreCyprotex specializes in ADME-Tox and Biosciences. We work with a range of customers in the pharmaceutical, chemical, personal care and cosmetic industries.
